These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37365668)

  • 21. Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial.
    McElroy SL; Hudson JI; Mitchell JE; Wilfley D; Ferreira-Cornwell MC; Gao J; Wang J; Whitaker T; Jonas J; Gasior M
    JAMA Psychiatry; 2015 Mar; 72(3):235-46. PubMed ID: 25587645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Group Intervention for Individuals With Obesity and Comorbid Binge Eating Disorder: Results From a Feasibility Study.
    Eik-Nes TT; Vrabel K; Raman J; Clark MR; Berg KH
    Front Endocrinol (Lausanne); 2021; 12():738856. PubMed ID: 34803910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lisdexamfetamine for binge eating disorder in adults: a systematic review of the efficacy and safety profile for this newly approved indication - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2015 Apr; 69(4):410-21. PubMed ID: 25752762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of obese patients with binge eating disorder using topiramate: a review.
    Leombruni P; Lavagnino L; Fassino S
    Neuropsychiatr Dis Treat; 2009; 5():385-92. PubMed ID: 19649212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of topiramate in binge eating disorder: a systematic review and meta-analysis.
    Nourredine M; Jurek L; Auffret M; Iceta S; Grenet G; Kassai B; Cucherat M; Rolland B
    CNS Spectr; 2021 Oct; 26(5):459-467. PubMed ID: 32641176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topiramate precipitating a manic episode in a bipolar patient comorbid with binge eating disorder: A case report.
    Duan J; Lai J; Wang D; Zhou W; Huang M; Hu S; Xu Y; Lu J
    Medicine (Baltimore); 2019 Apr; 98(17):e15287. PubMed ID: 31027088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.
    McElroy SL; Arnold LM; Shapira NA; Keck PE; Rosenthal NR; Karim MR; Kamin M; Hudson JI
    Am J Psychiatry; 2003 Feb; 160(2):255-61. PubMed ID: 12562571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial.
    Hudson JI; McElroy SL; Ferreira-Cornwell MC; Radewonuk J; Gasior M
    JAMA Psychiatry; 2017 Sep; 74(9):903-910. PubMed ID: 28700805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures.
    Hedges DW; Reimherr FW; Hoopes SP; Rosenthal NR; Kamin M; Karim R; Capece JA
    J Clin Psychiatry; 2003 Dec; 64(12):1449-54. PubMed ID: 14728106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating the feasibility and potential efficacy of a brief eTherapy for binge-eating disorder: A pilot study.
    Rom S; Miskovic-Wheatley J; Barakat S; Aouad P; Fuller-Tyszkiewicz M; Maguire S
    Int J Eat Disord; 2022 Nov; 55(11):1614-1620. PubMed ID: 35986579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overview of the treatment of binge eating disorder.
    McElroy SL; Guerdjikova AI; Mori N; Munoz MR; Keck PE
    CNS Spectr; 2015 Dec; 20(6):546-56. PubMed ID: 26594849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
    Perry MS
    Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures.
    Hoopes SP; Reimherr FW; Hedges DW; Rosenthal NR; Kamin M; Karim R; Capece JA; Karvois D
    J Clin Psychiatry; 2003 Nov; 64(11):1335-41. PubMed ID: 14658948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationships between clinical scales and binge eating days in adults with moderate to severe binge eating disorder in two Phase III studies.
    Citrome L; Kando JC; Bliss C
    Neuropsychiatr Dis Treat; 2018; 14():537-546. PubMed ID: 29497297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent self-administered transcranial direct current stimulation and attention bias modification training in binge eating disorder: feasibility randomised sham-controlled trial.
    Flynn M; Campbell IC; Schmidt U
    BJPsych Open; 2024 Jun; 10(4):e118. PubMed ID: 38840537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binge-eating disorder treatment goes online - feasibility, usability, and treatment outcome of an Internet-based treatment for binge-eating disorder: study protocol for a three-arm randomized controlled trial including an immediate treatment, a waitlist, and a placebo control group.
    Munsch S; Wyssen A; Vanhulst P; Lalanne D; Steinemann ST; Tuch A
    Trials; 2019 Feb; 20(1):128. PubMed ID: 30760299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physical and mental health outcomes of an integrated cognitive behavioural and weight management therapy for people with an eating disorder characterized by binge eating and a high body mass index: a randomized controlled trial.
    Hay P; Palavras MA; da Luz FQ; Dos Anjos Garnes S; Sainsbury A; Touyz S; Appolinario JC; Claudino AM
    BMC Psychiatry; 2022 May; 22(1):355. PubMed ID: 35610603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The feasibility of emotion-focused therapy for binge-eating disorder: a pilot randomised wait-list control trial.
    Glisenti K; Strodl E; King R; Greenberg L
    J Eat Disord; 2021 Jan; 9(1):2. PubMed ID: 33407948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the efficacy of the selective orexin 1 receptor antagonist nivasorexant in an animal model of binge-eating disorder.
    Steiner MA; Botticelli L; Bergamini G; Micioni Di Bonaventura E; Gatfield J; Williams JT; Treiber A; Vaillant C; Cifani C; Micioni Di Bonaventura MV
    Int J Eat Disord; 2024 Mar; ():. PubMed ID: 38456603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.